HomeScienceHi-C Metagenomics Maps Plasmid Network
SCIENCE

Hi-C Metagenomics Maps Plasmid Networks in Wastewater

A Nature Communications study reveals how wastewater treatment restricts plasmid hosts while allowing specific drug-resistant bacterial elements to endure.

WHAT YOU NEED TO KNOW
  • Hi-C metagenomics identified 944 plasmid clusters across influent, activated sludge, and effluent at three facilities.
  • Plasmid host ranges narrowed from influent to effluent across all monitored treatment plants.
  • Burkholderiaceae and Rhodocyclaceae were identified as primary hosts for beta-lactam, tetracycline, and sulfonamide resistance genes.
  • Research was funded by the NSF, NIH, U.S. Army Corps of Engineers, and the U.S.–Egypt Science and Technology Joint Fund.

Wastewater treatment processes narrow the host range of plasmids while preserving specific bacterial carriers of antibiotic resistance genes, according to a peer-reviewed study published September 7 in Nature Communications. Researchers tracked microbial communities across three water resource recovery facilities using Hi-C metagenomics to map how mobile genetic elements behave in situ during treatment.

The team identified 944 plasmid clusters across influent, activated sludge, and effluent stages. Each facility and stage showed specific plasmid distributions. Across all three plants, plasmid host ranges narrowed progressively from influent to effluent, showing that treatment stages selectively constrain plasmid–host pairings.

Certain mobile elements persisted through the treatment process despite the narrowing host ranges. Persistent plasmid clusters that contained detectable mobility markers showed a trend toward broader, less modular host networks than plasmid clusters lacking detected markers. Hi-C data directly linking antibiotic resistance genes to bacterial hosts revealed that the families Burkholderiaceae and Rhodocyclaceae served as prominent reservoirs. Across facilities, these two bacterial families frequently harbored resistance genes against beta-lactam, tetracycline, and sulfonamide antibiotics.

Researchers from Rice University, the University of Southern California, and Duke University conducted the work. The author group includes Siyi Zhou and Lauren B. Stadler from Rice, alongside Sarah E. Philo, Michael A. Saldana, and Adam L. Smith from USC. The authors declared no competing interests. Grants supporting the research included awards from the U.S.–Egypt Science and Technology Joint Fund, the U.S. Army Corps of Engineers ERDC-CERL, the National Science Foundation, and the National Institute of Allergy and Infectious Diseases.

Xentir Media
Xentir Media NewsroomSource-backed AI and technology coverage, drafted by Xentir's automated editorial system under fixed human-set rules. See our editorial policy and AI usage policy.
J
Jomon · Founder & EditorFounder and editor of Xentir Media. Sets the editorial rules the newsroom system runs under, and is accountable for its corrections. About Jomon · [email protected]
The Xentir Brief
The developments worth knowing — one useful email.
Get the Brief →